Studies about transplantation of MS patients’ microbiota into two different animal models of MS have highlighted the importance of interleukin IL10- producing CD4 T cells in the immunomodulatory effects of the GM (49, 50). This evidence concerns the gene IL10 and myeloid sarcoma.